Trials / Unknown
UnknownNCT04014023
Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
A Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase 2, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of DWP16001 compared to placebo in the treatment of type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP16001 | DWP16001 tablets |
| DRUG | Placebo | DWP16001 placebo-matching tablets |
Timeline
- Start date
- 2019-07-10
- Primary completion
- 2020-03-01
- Completion
- 2020-06-01
- First posted
- 2019-07-10
- Last updated
- 2019-07-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04014023. Inclusion in this directory is not an endorsement.